Teleflex to Present at the Jefferies Global Healthcare Conference in London
WAYNE, Pa., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Management of Teleflex Incorporated ( NYSE: TFX ) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. ( GMT ) .
Teleflex to Present at the Jefferies Global Healthcare Conference in London - Teleflex ( NYSE:TFX )
WAYNE, Pa., Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- Management of Teleflex Incorporated ( NYSE:TFX ) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. ( GMT ) .
TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down
Teleflex posts strong Q3 earnings and revenue beats but trims 2025 outlook, sending shares slightly lower.
These Analysts Cut Their Forecasts On Teleflex Following Q3 Results - Teleflex ( NYSE:TFX )
Teleflex Incorporated ( NYSE:TFX ) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus estimate of $3.38 per share.
Teleflex ( TFX ) Q3 Earnings and Revenues Surpass Estimates
Teleflex (TFX) delivered earnings and revenue surprises of +8.58% and +2.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Teleflex Announces Quarterly Dividend
WAYNE, Pa., Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE: TFX ) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ( $0.34 ) per share of common stock. The dividend is payable December 15, 2025, to shareholders of record at the ...
Teleflex Announces Quarterly Dividend - Teleflex ( NYSE:TFX )
WAYNE, Pa., Nov. 06, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE:TFX ) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ( $0.34 ) per share of common stock.
Pulse Biosciences, Inc ( PLSE ) Reports Q3 Loss, Lags Revenue Estimates
Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +6.45% and -82.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
STERIS to Report Q2 Earnings: Here's What to Expect
STE is set to post fiscal Q2 results on Nov. 6, with estimates pointing to solid revenue and earnings growth across key segments.
AVITA Medical Announces CEO Transition
VALENCIA, Calif., Oct. 16, 2025 ( GLOBE NEWSWIRE ) -- AVITA Medical, Inc. ( NASDAQ: RCEL, ASX: AVH ) ( "AVITA Medical", or the "Company" ) , a leading therapeutic acute wound care company, today announced that the Board of Directors has named Chairman of the Board Cary Vance as Interim Chief ...
AVITA Medical Announces CEO Transition - AVITA Medical ( NASDAQ:RCEL )
Board Chairman Cary Vance appointed Interim CEO Board member Jan Stern Reed appointed Lead Independent Director Third quarter 2025 preliminary revenue expected to be approximately $17 million
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
WAYNE, Pa., Oct. 16, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE:TFX ) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025.
TFX vs. PEN: Which Stock Should Value Investors Buy Now?
TFX vs. PEN: Which Stock Is the Better Value Option?
Should Value Investors Buy Teleflex ( TFX ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and ...
Waters ( WAT ) Up 5.4% Since Last Earnings Report: Can It Continue?
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI
Teleflex, Integer Holdings and Inogen are defying tariff and supply chain headwinds with genAI-driven momentum within the Medical Instruments industry.
Are Investors Undervaluing Teleflex ( TFX ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - Teleflex ( NYSE:TFX )
WAYNE, Pa., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Management of Teleflex Incorporated TFX will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. ( ET ) .
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
WAYNE, Pa., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Management of Teleflex Incorporated ( NYSE: TFX ) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. ( ET ) .
TFX or SONVY: Which Is the Better Value Stock Right Now?
TFX vs. SONVY: Which Stock Is the Better Value Option?
Teleflex Stock Gains Following Barrigel's Launch in Japan
TFX stock jumps 3.7% after launching Barrigel in Japan, marking a milestone in its global expansion strategy.
4 PEG-Based Value Stocks That Could Help You Crush the Market
Itron, Teleflex, Popular and PHINIA emerge as PEG-based value picks with growth potential despite market volatility.
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy - Teleflex ( NYSE:TFX )
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4 Initial cases have now been performed in Japan.
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4Initial cases have now been performed in Japan.
Should Value Investors Buy Teleflex ( TFX ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
TFX vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Teleflex ( TFX Quick QuoteTFX - ) and SONOVA HOLDING ( SONVY Quick QuoteSONVY - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Is Tactile Systems Technology ( TCMD ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teleflex ( TFX ) Q2 Earnings and Revenues Top Estimates
Teleflex (TFX) delivered earnings and revenue surprises of +11.01% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Teleflex Announces Quarterly Dividend
WAYNE, Pa., July 31, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE: TFX ) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ( $0.34 ) per share of common stock. The dividend is payable September 15, 2025, to shareholders of record at the ...
Teleflex Announces Quarterly Dividend - Teleflex ( NYSE:TFX )
WAYNE, Pa., July 31, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated TFX announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ( $0.34 ) per share of common stock. The dividend is payable September 15, 2025, to shareholders of record at the close of ...
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
WAYNE, Pa., July 31, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE: TFX ) ( the "Company" ) today announced financial results for the second quarter ended June 29, 2025.
Analysts Estimate Teleflex ( TFX ) to Report a Decline in Earnings: What to Look Out for
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
WAYNE, Pa., July 17, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE:TFX ) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 31, 2025.
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up
TFX gains 2.9% after acquiring BIOTRONIK's vascular unit, boosting its cath lab presence and innovation pipeline.
Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business - Teleflex ( NYSE:TFX )
WAYNE, Pa., July 01, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated TFX, a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG. The ...
Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business
WAYNE, Pa., July 01, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE:TFX ) , a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG. ...
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
WAYNE, Pa., June 12, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated ( NYSE: TFX ) , a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters ( CVCs ) .
3 Reasons Why Vanguard's Worst-Performing ETF in 2025 May Be Worth Buying in June
Investment management firm Vanguard Group has over 90 exchange-traded funds ( ETFs ) , many of which offer low-cost fees. The worst-performing in 2025 is the Vanguard Small-Cap 600 Value ETF ( NYSEMKT: VIOV ) -- which is down just over 12% year to date at the time of this writing.Here are three ...
Integra ( IART ) Up 2.3% Since Last Earnings Report: Can It Continue?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chronic Total Occlusion Market Size to Surpass USD 42.21 Billion by 2031, Increasing Prevalence of Cardiovascular Diseases Fuels | The Insight Partners
US & Canada, May 20, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the chronic total occlusion market is observing significant growth owing to the increasing prevalence of cardiovascular diseases and strategic initiatives by market players.
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated ( NYSE: TFX ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Teleflex ( NYSE:TFX )
NEW YORK, May 19, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated TFX resulting from allegations that Teleflex may have issued materially misleading ...
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
enVVeno Medical Corporation ( NASDAQ:NVNO ) ( "enVVeno" or the "Company" ) , a company setting new standards of care for the treatment of deep venous disease, announced the appointment of Jennifer Bright as Chief Financial Officer, effective today, May 19, 2025.
Teleflex Publishes 2024 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program ...
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association ( AUA ) Annual Meeting - Teleflex ( NYSE:TFX )
Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for BPH1-2 First-Ever Analysis Utilizing the American Urological Association Quality Registry ( AQUA ) to Assess BPH Treatment Modalities Shows Strongest Symptom Improvement Score Shift with ...
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association ( AUA ) Annual Meeting
Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for ...
Teleflex Announces Quarterly Dividend - Teleflex ( NYSE:TFX )
WAYNE, Pa., May 12, 2025 ( GLOBE NEWSWIRE ) -- Teleflex Incorporated TFX announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ( $0.34 ) per share of common stock. The dividend is payable June 16, 2025, to shareholders of record at the close of ...
C. Duncan Takes A Bullish Stance, Acquiring Teleflex Stock Options Worth $0 - Teleflex ( NYSE:TFX )
On May 7, Duncan, Board Member at Teleflex TFX, executed a strategic insider move by acquiring stock options for 0 shares. What Happened: Uncovered in a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission, Duncan, Board Member at Teleflex, executed an insider options move.
Should iShares S&P Small-Cap 600 Value ETF ( IJS ) Be on Your Investing Radar?
Style Box ETF report for ...
How Is The Market Feeling About Teleflex? - Teleflex ( NYSE:TFX )
Teleflex's TFX short percent of float has fallen 37.05% since its last report. The company recently reported that it has 1.56 million shares sold short, which is 5.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.42 days to cover their ...
